Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

Elisa K. Yoo, Maureen Cassin, Stuart R. Lessin, Alain H. Rook

Journal of the American Academy of Dermatology · 2001 · 82 citations · 37 references

Concepts

References

37